Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Oct. 28, 2017	Oct. 29, 2016	Oct. 31, 2015
Cash flows from operating activities:
Net Income	$ 727,259	$ 861,664	$ 696,878
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	194,666	134,540	130,147
Amortization of intangibles	389,393	75,250	92,093
Cost of goods sold for inventory acquired	358,718	0	0
Stock-based compensation expense	104,188	63,421	68,919
Loss on extinguishment of debt	0	3,290	0
Other non-cash activity	(10,865)	24,570	6,974
Excess tax benefit — equity based awards	(41,773)	(10,453)	(25,045)
Deferred income taxes	(825,869)	8,124	(52,214)
Change in operating assets and liabilities:
Accounts receivable	(65,669)	(9,392)	(71,198)
Inventories	(47,354)	38,221	(35,557)
Prepaid expenses and other current assets	(1,875)	(5,618)	2,861
Deferred compensation plan investments	(7,358)	(2,399)	(2,643)
Prepaid income tax	2,679	(4,315)	4,546
Accounts payable, deferred income and accrued liabilities	192,249	85,502	56,614
Deferred compensation plan liability	7,358	2,399	2,643
Income taxes payable	119,618	9,950	25,060
Other liabilities	17,227	6,141	7,720
Total adjustments	385,333	419,231	210,920
Net cash provided by operating activities	1,112,592	1,280,895	907,798
Cash flows from investing:
Purchases of short-term available-for-sale investments	(705,485)	(7,697,260)	(6,083,999)
Maturities of short-term available-for-sale investments	3,362,792	6,375,361	4,984,980
Sales of short-term available-for-sale investments	577,187	332,716	1,251,194
Additions to property, plant and equipment, net	(204,098)	(127,397)	(153,960)
Payments for acquisitions, net of cash acquired	(9,632,568)	(83,170)	(7,065)
Change in other assets	(15,842)	(18,520)	(8,275)
Net cash used for investing activities	(6,618,014)	(1,218,270)	(17,125)
Cash flows from financing activities:
Proceeds from debt	11,156,164	1,235,331	0
Debt repayments	(5,050,000)	0	0
Early termination of debt	0	(378,156)	0
Proceeds from (payments of) derivative instruments	3,904	(33,430)	0
Payments of deferred financing fees	(5,625)	(26,583)	0
Dividend payments to shareholders	(602,119)	(513,180)	(491,059)
Repurchase of common stock	(46,533)	(370,061)	(226,953)
Proceeds from employee stock plans	133,302	61,496	122,631
Contingent consideration payment	(1,764)	(1,409)	(1,767)
Change in other financing activities	(524)	(7,378)	500
Excess tax benefit — equity based awards	41,773	10,453	25,045
Net cash provided by (used for) financing activities	5,628,578	(22,917)	(571,603)
Effect of exchange rate changes on cash	3,550	(2,929)	(3,950)
Net increase in cash and cash equivalents	126,706	36,779	315,120
Cash and cash equivalents at beginning of year	921,132	884,353	569,233
Cash and cash equivalents at end of year	$ 1,047,838	$ 921,132	$ 884,353